Dr. Rosemary B Desloge

Dr. Rosemary B Desloge (DR. ROSEMARY B DESLOGE ) is An Otolaryngology Physician in New York, NY. The NPI Number for Dr. Rosemary B Desloge is 1982656351.

The current location address for Dr. Rosemary B Desloge is 969 PARK AVE SUITE 1C New York, NY 10028 and the contact number is 2127172700 and fax number is 2127172701. The mailing address for Dr. Rosemary B Desloge is 969 PARK AVE SUITE 1C New York, NY 10028- 2127172700 (mailing address contact number - 2127172700).

An otolaryngologist-head and neck surgeon provides comprehensive medical and surgical care for patients with diseases and disorders that affect the ears, nose, throat, the respiratory and upper alimentary systems and related structures of the head and neck. An otolaryngologist diagnoses and provides medical and/or surgical therapy or prevention of diseases, allergies, neoplasms, deformities, disorders and/or injuries of the ears, nose, sinuses, throat, respiratory and upper alimentary systems, face, jaws and the other head and neck systems. Head and neck oncology, facial plastic and reconstructive surgery and the treatment of disorders of hearing and voice are fundamental areas of expertise.

What is the NPI Number for Dr. Rosemary B Desloge ?

Answer: The NPI Number for Dr. Rosemary B Desloge is 1982656351

Where is Dr. Rosemary B Desloge located?

Answer: Dr. Rosemary B Desloge is located at 969 PARK AVE SUITE 1C New York, NY 10028.

What is the specialty for Dr. Rosemary B Desloge ?

Answer: The Specialty of Dr. Rosemary B Desloge is An Otolaryngology Physician.

Are there any online reviews for Dr. Rosemary B Desloge ?

Answer: Yes! Check It Now.

Are there any other health care providers in New York, NY?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Otolaryngology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	329
Number of Standardized 30-Day Fills	429
Aggregate Cost Paid for All Claims	28015.72
Number of Day's Supply for All Claims	11530
Number of Medicare Beneficiaries	90
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	67
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	262
Aggregate Cost Paid for Generic Drugs	4477.37
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	23
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	214.99
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	306
Aggregate Cost Paid for Claims Filled by	27800.73
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	0
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	0
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	329
by Low-Income Subsidy	28015.72
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	33
Aggregate Cost Paid for Antibiotic Drugs	533.1
Antibiotic Claims	23
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	77.555555556
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	54
Number of Male Beneficiaries	36
Number of Non-Hispanic White	78
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement	90
Average Hierarchical Condition Category	0.8607333333